CD4+T-cells have a central role in induction and homeostasis of the immune response, and are also the major target cells for HIV. HIV has devised mechanisms to subvert the immune system and further its cause of survival and dissemination. vpr is one of the accessory genes, which is essential for the virus survival in vivo. Being a soluble protein with an ability to transduce across cell membranes, Vpr can potentially affect bystander cells. We hypothesize that HIV-1 Vpr alters the functions of both infected and bystander T lymphocytes, utilizing direct and indirect mechanisms, and these Vpr-mediated effects contribute in part to the immune dysregulation, and aid in viral dissemination. The Specific Aims of this proposal are to: (1) Assess the immune modulatory effects of Vpr in infected and bystander T-lymphocytes; (2) Understand the role of Vpr in T lymphocytes, natural killer (NK) cells and dendritic cells (DC) interactions; and (3) Analyze the structure-function role of Vpr in immunopathogenesis. We utilized HIV-1wt and HIV-1ΔVpr viruses and compared the difference in the effects of these viruses under controlled simulated invitro conditions. The differences observed in the effect of these two viruses can be attributed to Vpr provided that the infections in both the experimental sets are similar. In some studies, to clearly identify infected cells, we employed EGFP reporter viruses. The effects in infected cells and bystander cells were evaluated. Results indicate that HIV-1 Vpr has a role in dysregulation of immune cells during HIV infection. Vpr differentially regulates the surface expression of T cell costimulatory molecules, CD28 and CTLA-4, and inhibits IFN-γ production in infected T cells. Vpr also inhibits NK cell function by augmenting TGF-β production and inducing altered expression of NK receptor ligands. Further, oligomerization of Vpr has a role in gag incorporation of Vpr and in viral pathogenesis. The findings presented in this study are significant for public health because mechanistic understanding of the pathogenesis will aid in development of novel anti-viral therapeutics.
| Identifer | oai:union.ndltd.org:PITT/oai:PITTETD:etd-04072009-164042 |
| Date | 29 June 2009 |
| Creators | Venkatachari, Narasimhan Jayanth |
| Contributors | Todd A. Reinhart, ScD, Frank J. Jenkins, PhD., Velpandi Ayyavoo, PhD., Charles R. Rinaldo Jr., PhD |
| Publisher | University of Pittsburgh |
| Source Sets | University of Pittsburgh |
| Language | English |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | http://etd.library.pitt.edu/ETD/available/etd-04072009-164042/ |
| Rights | restricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to University of Pittsburgh or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report. |
Page generated in 0.01 seconds